The high prices of many patented pharmaceuticals, especially chemotherapy drugs, pose substantial challenges to the budgets of public programs, private insurers, and patients and their families. Addressing this problem in the US context, through changes
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/05/11/would-a-wider-variety-of-vial-sizes-reduce-the-cost-of-chemotherapy-not-likely/
Posted
May 11 2016, 10:00 AM
by
Health Affairs BlogHealth Affairs Blog